Literature DB >> 8206143

On the introduction of genetically modified Leishmania outside the laboratory.

F J Gueiros-Filho1, S M Beverley.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8206143     DOI: 10.1006/expr.1994.1048

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


× No keyword cloud information.
  6 in total

1.  Cos-Seq for high-throughput identification of drug target and resistance mechanisms in the protozoan parasite Leishmania.

Authors:  Élodie Gazanion; Christopher Fernández-Prada; Barbara Papadopoulou; Philippe Leprohon; Marc Ouellette
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-09       Impact factor: 11.205

2.  An axenic amastigote system for drug screening.

Authors:  H L Callahan; A C Portal; R Devereaux; M Grogl
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

3.  Generating and Maintaining Transgenic Cryptosporidium parvum Parasites.

Authors:  Mattie C Pawlowic; Sumiti Vinayak; Adam Sateriale; Carrie F Brooks; Boris Striepen
Journal:  Curr Protoc Microbiol       Date:  2017-08-11

4.  Development of a safe live Leishmania vaccine line by gene replacement.

Authors:  R G Titus; F J Gueiros-Filho; L A de Freitas; S M Beverley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  Selection against the dihydrofolate reductase-thymidylate synthase (DHFR-TS) locus as a probe of genetic alterations in Leishmania major.

Authors:  F J Gueiros-Filho; S M Beverley
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

6.  Genetic modification of the diarrhoeal pathogen Cryptosporidium parvum.

Authors:  Sumiti Vinayak; Mattie C Pawlowic; Adam Sateriale; Carrie F Brooks; Caleb J Studstill; Yael Bar-Peled; Michael J Cipriano; Boris Striepen
Journal:  Nature       Date:  2015-07-15       Impact factor: 49.962

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.